Remedy’s Strategic Move: Acquires Thirty Madison in Multimillion-Dollar All-Stock Deal

health needs.">

September 7, 2025

New York, NY – Remedy Meds, Llc, a rapidly growing consumer virtual-care and pharmacy platform, has announced a definitive agreement to acquire Thirty Madison, Inc. The transaction, valued at just over $500 million, will be completed entirely through stock exchange and is expected to finalize in the fourth quarter of 2025, subject to standard regulatory approvals.

A New Powerhouse in Consumer Healthcare

This acquisition will result in a more extensive, multi-brand platform addressing womenS health, men’s wellness, and metabolic health concerns. The combined company aims to deliver convenient, cost-effective, and high-quality care to a broader patient base.

Uniting Expertise and Infrastructure

Thirty Madison, recognized as a leader in virtual specialty care, will integrate its capabilities with Remedy Meds’ established infrastructure. The collaboration will offer a comprehensive suite of services encompassing men’s hair loss solutions, women’s health support, migraine management, and weight management programs. Patients will have access to same-day video consultations,expedited prescription reviews,customized treatment plans,and direct-to-door medication delivery.

The newly formed entity will incorporate Remedy Meds, Keeps, Nurx, and Cove-prominent brands each catering to specific health needs. By uniting these brands, the company anticipates enhanced patient trust and streamlined operations.

Financial Synergies and Growth Potential

Remedy Meds currently generates over $450 million in annual revenue, demonstrating strong profitability. This financial strength will complement Thirty Madison’s existing $220 million-plus profitable business, creating a scalable and enduring operating model.

Company	Annual revenue (Approximate)	Primary Focus
Remedy Meds	$450M+	Weight Loss & Pharmacy
thirty Madison	$220M+	Virtual Specialty Care
Combined Entity	$670M+	Multi-Brand Consumer health

“By integrating Thirty Madison’s respected brands with Remedy Meds’ customer acquisition expertise, patient retention strategies, and advanced pharmacy infrastructure, we aim to increase accessibility, accelerate treatment timelines, and uphold the financial prudence that has steered our success,” stated Haris Memon, Founder and CEO of Remedy Meds.

Did You Know? The telehealth market has experienced significant growth in recent years, driven by increased demand for convenient and accessible healthcare options. according to a recent report by Fortune Business Insights, the global telehealth market is projected to reach $431.82 billion by 2030.

the Rise of Virtual Healthcare

The trend towards virtual healthcare is not new, but it has been drastically accelerated by recent global events and technological advancements. Consumers are increasingly seeking solutions that offer convenience,affordability,and personalized care. This acquisition reflects a broader industry shift towards integrated,multi-specialty telehealth platforms.

The success of companies like Teladoc Health and Amwell demonstrates the viability of the telehealth model. Though, manny patients still face challenges in accessing specialized care. This is where companies like Remedy Meds and Thirty Madison are seeking to differentiate themselves by focusing on specific health needs and providing tailored solutions.

Pro Tip: When evaluating telehealth options, consider factors such as insurance coverage, clinician qualifications, and the platform’s security measures to ensure a positive and safe experience.

Frequently Asked Questions About the Remedy Meds and Thirty Madison Acquisition

• What is the primary goal of this acquisition? the main goal is to create a larger, more comprehensive telehealth platform that offers a wider range of services to consumers.
• When is the acquisition expected to close? The transaction is anticipated to close in Q4 2025, pending regulatory approvals.
• What brands will be part of the combined company? Remedy Meds, Keeps, Nurx, and Cove will all be part of the new platform.
• How will this acquisition benefit patients? Patients will benefit from increased access to care, personalized treatment plans, and convenient medication delivery.
• Is this deal all cash? No, the transaction will be funded through an all-stock deal.

What are your thoughts on the growing trend of telehealth consolidation? Do you think this will lead to better or worse outcomes for patients?

Share your opinions and join the conversation in the comments below!

What are the key financial terms of the Remedy-Thirty madison acquisition?

Deal Overview & Financial Details

Remedy, a leading virtual specialty care provider, has announced the acquisition of Thirty Madison, a digital health company focused on chronic condition management. The deal, structured as an all-stock transaction, is valued in the multimillions, though the precise figure remains undisclosed. This strategic move signals Remedy’s continued expansion within the rapidly growing digital healthcare landscape and its commitment to providing accessible, affordable, and high-quality care. Key terms of the deal include:

All-Stock Transaction: Remedy is acquiring Thirty Madison using only company stock, conserving cash resources.

Expansion of Service Offerings: The acquisition broadens Remedy’s portfolio to include Thirty Madison’s specialized programs in areas like dermatology, cardiology, and mental health.

Synergies in Technology: Both companies leverage technology to deliver virtual care, creating opportunities for integration and enhanced patient experiences.

Strengthened Market Position: The combined entity will have a larger footprint in the virtual specialty care market, increasing its competitive advantage.

Thirty Madison’s Core Strengths & Specializations

Thirty Madison has carved a niche for itself by offering specialized virtual care programs designed to address specific chronic conditions. their approach focuses on personalized treatment plans, convenient access to board-certified specialists, and data-driven insights.Their key areas of focus include:

Dermatology: Offering online consultations, prescription delivery, and ongoing skin health management.

Cardiology: Providing remote monitoring, medication management, and lifestyle coaching for cardiovascular health.

Mental Health: Delivering virtual therapy and psychiatric services for a range of mental health conditions.

Gastroenterology: Focused on digestive health, offering virtual consultations and treatment plans.

this specialization complements Remedy’s existing offerings, creating a more thorough suite of virtual care solutions. The integration of Thirty Madison’s expertise will be crucial for Remedy’s long-term growth strategy.

Remedy’s Growth Strategy & Rationale behind the Acquisition

Remedy has been on a trajectory of rapid growth, fueled by increasing demand for virtual care solutions. This acquisition aligns with their broader strategy to:

1. Expand into New Specialties: Thirty Madison’s specialized programs allow Remedy to quickly enter new markets and address a wider range of patient needs.
2. Enhance Patient Access: Combining the platforms will increase access to specialty care for patients in underserved areas.
3. Drive innovation in Virtual Care: The integration of technologies and clinical expertise will foster innovation in virtual care delivery.
4. Improve Patient Outcomes: Personalized treatment plans and ongoing monitoring are expected to lead to improved patient outcomes.

Remedy’s leadership views this acquisition as a pivotal step in becoming a leading provider of virtual specialty care, offering a comprehensive and integrated healthcare experience.The company is actively seeking opportunities to expand its reach and impact through strategic partnerships and acquisitions.

Impact on the virtual Healthcare Market

This deal underscores the continued consolidation within the virtual healthcare market. Several factors are driving this trend:

Increased Investment: The virtual healthcare market has attracted important investment in recent years, leading to increased competition.

Demand for Scalability: Acquisitions allow companies to quickly scale their operations and reach a larger patient base.

Need for specialization: As the market matures, companies are focusing on specialized areas of care to differentiate themselves.

Pressure to Demonstrate Value: Payers and employers are demanding evidence of value from virtual care providers, driving the need for integrated solutions.

the Remedy-Thirty Madison deal is expected to spur further consolidation in the industry, as companies seek to gain market share and achieve economies of scale. this will likely result in more comprehensive and integrated virtual care offerings for patients.

Integration Plans & Future Outlook

Remedy has outlined plans for a phased integration of Thirty Madison’s operations. Key priorities include:

Technology Integration: Combining the platforms to create a seamless patient experience.

Clinical Alignment: Integrating clinical protocols and best practices.

* Brand Management: Determining